MDD/GAD Drugs Exam 1 + 2

0.0(0)
Studied by 7 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/75

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:47 PM on 9/4/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

76 Terms

1
New cards

Citalopram

Brand: Celexa
Class: SSRI

Monitor: EKG → d/c if QTc persistently >500 ms

Dose >40 mg/day NOT recommended → MAX 20 for:

  • CYP2C19 poor metabolizer

  • Coadminister w/ CYP2C19 inhibitors

  • Pts > 60 y/o


2
New cards

Escitalopram

Brand: Lexapro
Class: SSRI

Best tolerated SSRI

Pearls:

  • ↑ absorption with food

  • GI adverse effects

  • preferred during breastfeeding


3
New cards

Fluoxetine

Brand: Prozac
Class: SSRI

  • Half Life: 4-6 days → no need to taper

  • Stimulating → give in AM

  • Potent CYP2D6 inhibitor

  • 5 week washout required if switching to MAOI

  • higher odds for birth defects


4
New cards

Paroxetine

Brand: Paxil, Brisdelle, Pexeva
Class: SSRI

Shortest half life (21 H) → NO active metabolite

TAPER if planning to D/C

SE:

  • constipation

  • dry mouth

  • sedation

  • weight gain

  • SEX Dysfunction (possibly has the most of all SSRI)

Potent CYP2D6 Inhibitor

Pearls:

  • avoid in pregnancy

  • on Beer’s List

  • higher odds for birth defects → 2 fold ↑ risk of cardiac malformations


5
New cards

Sertraline

Brand: Zoloft
Class: SSRI

Do NOT use Solution with Disulfiram

6
New cards

Vilazodone

Brand: Viibryd
Class: SSRI and 5-HT1a partial agonist

Pearls:

  • need to take with food

  • diarrhea and nausea

  • may have LESS sexual SE


7
New cards

Vortioxetine

Brand: Trintellix
Class: SSRI and 5-HT subtype agonist/antagonist → help concentration

Pearls:

  • less sexual SE

  • diarrhea/constipation → GI issues

  • more aware/functional

  • long half life → 66 H (3 days)

  • okay to abruptly d/c

21 day washout required if switching to MAOI

8
New cards

Venlafaxine

Brand: Effexor (XR)
Class: SNRI

Pearls:

  • dose < 150 mg/day → primarily affects 5-HT → acts more like SSRI

  • withdrawal upon D/C (Brain Zaps)

  • XR best tolerated

  • dose-dependent risk of ↑ BP

  • Fatal in OD → d/t QT prolongation

  • Pregnancy safe


9
New cards

Duloxetine

Brand: Cymbalta
Class: SNRI

Other Indication: peripheral pain, fibromyalgia, chronic musculoskeletal pain

CYP2D6 Inhibitor


10
New cards

Desvenlafaxine

Brand: Pristiq, Khedezla
Class: SNRI

Active Metabolite of Venlafaxine (via 2D6 metabolism)

11
New cards

Levomilnacipran

Brand: Fetzima
Class: SNRI

12
New cards

Amitriptyline

Brand: Elavil
Class: TCA

13
New cards

Clomipramine

Brand: Anafranil
Class: TCA

14
New cards

Imipramine

Brand: Tofranil
Class: TCA

15
New cards

Desipramine

Brand: Norpramin
Class: TCAs

16
New cards

Nortriptyline

Brand: Pamelor
Class: TCA

17
New cards

Bupropion

Brand: Wellbutrin, Aplenzin, Forfivo
Class: DNRI (dopamine NE reuptake inhibitor)

FDA approved: smoking cessation (Zyban)

Stimulating → give in AM

Avoid in: seizure disorders, eating disorders, alcoholics

Caution: pts w/ psychosis

SE:

  • ↑ BP

  • weight loss

  • transient anxiety (worsens existing anxiety disorder)

  • sweating

CYP2D6 inhibitor

Sex Dysfunction Low Risk

18
New cards

Isocarboxazid

Brand: Marplan
Class: MAOIs

19
New cards

Phenelzine

Brand: Nardil
Class: MAOIs

20
New cards

Tranylcypromine

Brand: Parnate
Class: MAOIs

21
New cards

Selegiline

Brand: Emsam (transdermal patch)
Class: MAOIs

MOA: selective MAO-B inhibition

Reserved for: refractory depression

Formulations: transdermal patch or PO

Patch Dosing:

  • 6 mg → does NOT require tyramine-free diet

  • 9 and 12 mg → tyramine mediated hypertensive rxn may occur


22
New cards

Mirtazapine

Brand: Remeron
Class: atypical antidepressant/NaSSA (noradrenergic + specific serotonergic)

MOA: block alpha2 and H1 → ↑ 5-HT, NE, sedation

SE: sedation, ↑ appetite, weight gain

Low sex dysfunction risk

Note: ↑ dose → ↓ sedation

“CA Rocket Fuel” when combined w/ SNRI

23
New cards

Trazodone

Brand: Desyrel
Class: atypical antidepressant/SARIs (5-HT antagonist + Reuptake inhibitors)

MOA: SSRI + H1 blocker → 😴

SE: sedation, priapism (rare)


24
New cards

Nefazodone

Brand: Serzone
Class: atypical antidepressant/SARIs

MOA: SSRI + 5-HT/NE reuptake blocker

BBW: hepatotoxicity

D/C if ALT/AST >3x upper limit of normal

25
New cards

Esketamine

Brand: Spravato
Class/MOA: NMDA receptor antagonist

C3

FDA Approved: Adjunctive to antidepressant for tx resistant depression

BBW:

  • abuse/misuse

  • REMS → requires:

    • only admin in healthcare w/ ≥ 2 hours monitoring

    • healthcare settings/pharmacy need certification

    • pt enrollment in registry

  • suicidal thoughts and behavior

  • NOT approved in peds

  • dissociation → resolves about 1.5 hours post admin

  • sedation → peak effect 30-45 mins

SE: ↑ BP


26
New cards

Olanzapine/Fluoxetine

Brand: Symbyax

Indication: Tx resistant depression

27
New cards

Fluvoxamine

Brand: Luvox

Class: SSRI

Approved for OCD

Inhibitor of CYP: 1A2, 2C19, 2C9, 3A4

28
New cards

Dextromethorphan HBr and Bupropion HCl

Brand: Auvelity

Class: DNRI

MOA:

  • DM → NMDAr antagonist & sigma-1 agonist

  • Bupropion → inhibit DA/NE reuptake

Fast acting as soon as 2nd week

29
New cards

Bupropion Max Single Dosing

  • SR → Wellbutrin SR, Zyban: 200 mg

  • ER → Wellbutrin XL, Forfivo: 450 mg

  • Bupropion HBr → Aplenzin: 522 mg


30
New cards

Trazodone Dose for Depression

150-600 mg

31
New cards

Trazodone Dose for Insomnia

25-150 mg

32
New cards

Doxepin

Brand: Sinequan

Class: TCA

33
New cards

Despramine

Brand: Norpramin

Class: TCA (s)

34
New cards

Amoxapine

Brand: Asendin

Class: TCA

35
New cards

Trimipramine

Brand: Surmontil

Class: TCA

36
New cards

MAOI Drug Interactions → Risk of Hypertensive Crisis

Sympathomimetics

  • decongestants

  • stimulants

  • TCA

  • appetite suppressants (phentermine)

  • levodopa


37
New cards

MAOI Drug Interactions → Risk of Serotonin Syndrome

Serotonergic Agents

  • SSRI, SNRI, NaSSA

  • antihistamine

  • opioids (tramadol, fentanyl)

  • triptans

  • linezolid


38
New cards

What are Hypertensive Crisis Sx?

  • stiff neck

  • HA

  • vomiting

  • diaphoresis

  • HTN (DBP > 120)

  • palpitations

  • Labile HR


39
New cards

What is the Hypertensive Crisis Tx?

↓ BP → Phentolamine IV

40
New cards

CYP2D6 inhibitors and substrates?

Inhibitors:

  • Bupropion

  • Duloxetine

  • Fluoxetine

  • Paroxetine

Substrates: codeine, tramadol, clonidine, atomoxetine

41
New cards

What antidepressants have POTENT 2D6 inhibitory potential?

  • Bupropion

  • Fluoxetine

  • Paroxetine


42
New cards

CYP1A2 inhibitors and substrates?

Inhibitor: Fluvoxamine

Substrates: caffeine, clozapine, warfarin

43
New cards

What antidepressants should be avoided in elderly?

Strong Anticholinergics → Paroxetine, TCA

Risk of SIADH/Hyponatremia → SSRI, SNRI, Mirtazapine, TCA

44
New cards

What antidepressant is 1st line in pregnancy?

SSRI → Sertraline, Citalopram

45
New cards

Although generally avoided d/t anticholinergic properties, what TCAs are okay to use during pregnancy?

  • amitriptyline

  • imipramine

  • nortripyline


46
New cards

Zuranolone

Brand: Zurzuvae

C4

MOA: GABA-A receptor positive modulator

FDA Approved: post partum depression (PPD)

Dosing: 50 mg PO QD evening for 14 days

BBW: impaired ability to drive or engage in potentially hazardous activites

SE: somnolence, dizziness

Potential for abuse and dependence

47
New cards

What alternative meds/supps ↑ risk of 5-HT syndrome?

  • St. John’s Wort

    • similar efficacy to low dose meds for mild/mod depression

    • CYP3A4 Inducer

  • SAMe

  • 5-HTP (5- hydroxytryptophan)


48
New cards

Folate/Folic Acid (B9) is associated with depression. True or False.

True

  • adjunctive → improves depression scores in SSRI nonresponders


49
New cards

L-methylfolate

Brand: Deplin

MOA: active form of folic acid

Rx product → “medical food”

50
New cards

Time to Onset of Effects - What changes in the 1st week?

  • anxiety

  • sleep

  • appetite

  • energy


51
New cards

Time to Onset of Effects - What changes in the 2nd week?

  • self-care

  • memory

  • concentration

  • movements

  • sex drive


52
New cards

Time to Onset of Effects - What changes in the 4rd week?

  • depression

  • feelings of hopelessness


53
New cards

Time to Onset of Effects - What changes in the 4th week?

  • FULL RESPONSE

  • less helpless

  • less suicidal thoughts


54
New cards

What antidepressants induce anxiety?

  • Bupropion

  • SSRI

  • SNRI


55
New cards

What antiseizure meds induce anxiety?

  • carbamazepine

  • phenytoin


56
New cards

What dopamine agonist meds induce anxiety?

  • amantadine

  • levodopa


57
New cards

What substances induce anxiety?

  • ecstasy

  • cannabis

  • cocaine


58
New cards

What stimulants induce anxiety?

  • amphetamines

  • methylphenidate

  • caffeine

  • nicotine

  • cocaine


59
New cards

What bronchodilators induce anxiety?

  • albuterol

  • Theophylline


60
New cards

What somatic meds induce anxiety?

  • quinolones

  • prednisone

  • pseudophedrine

  • phenylephrine

  • levothyroxine


61
New cards

BZDs - MOA, Result, Use, SE, PK

MOA: enhance GABA inhibitory effects by binding to allosteric site on GABA-A receptor → ↑ affinity of GABA binding

Result: Rapid relief, Short-term tx, Acute anxiety

Uses: Anxiolysis, Insomnia, Seizures, Muscle relaxant activity

SE: drowsiness, ataxia, ↓ alertness/concentration

PK:

-  All → hepatic metabolism (CYP3A4)

-  Dose dependent highly sedating → low dose (sedating), high (hypnotic)

62
New cards

Flumazenil

Brand: Romazicon

Class: BZD Antidote

MOA: competitive GABA receptor antagonist

Use: counteract AE of BZDs

Admin IV

Potential to cause seizures & arrhythmias

PK: Rapid onset → may induce w/drawls

Short DOA

63
New cards

Buspirone

Brand: BuSpar

MOA: unknown; affinity for 5-Ht1A & 5-HT2 receptors

Non-BZD or CNS depressant

Non-sedating anti-anxiety agent

SE: dizziness, drowsiness, nausea, HA, tachycardia, nervousness

CI: MAOI → ↑ risk of serotonin syndrome

Avoid in severe liver or kidney impairment

Major CYP3A4 substrate:

  • ↓ dose if used with inhibitor (diltiazem, itraconazole)

  • ↑ dose if used with inducer (rifampin)


64
New cards

Propanolol

Brand: Inderal, InnoPran

MOA: competitive, non-selective beta 1 & 2 adrenergic blocker

Result: blocks “fight or flight” of heart and lungs → ↓ palpitations, fast HR, dizziness, shaking, sweaty palms

Treats physical sx of anxiety only !!!

Off-Label (low dose): stage fright & performance anxiety

PK:

-  Fast onset → within 1 hour

-  Effects last → 3-4 hours

SE: hypotension, bradycardia, arrhythmias, bronchospasm

65
New cards

Alprazolam

Brand: Xanax

Class: BZD

66
New cards

Clonazepam

Brand: Klonopin

Class: BZD

67
New cards

Diazepam

Brand: Valium

Class: BZD

68
New cards

Lorazepam

Brand: Ativan

Class: BZD

69
New cards

Chlordiazepoxide

Brand: Librium

Class: BZD

70
New cards

Clorazepate

Brand: Tranxene

Class: BZD

71
New cards

Oxazepam

Brand: Serax

Class: BZD

72
New cards

Temazepam

Brand: Restoril

Class: BZD

73
New cards

Advantages of BuSpar

  • no potential for abuse, tolerance, or dependence

  • anxiolytic effects as effective as BZD

  • chronic anxiety

  • long term tx

  • no marked sedation

  • less psychomotor impairments

  • abrupt D/C does NOT cause rebound or w/drawls


74
New cards

Disadvantages of BuSpar

  • slow or delayed onset

  • takes 3-4 weeks to work

  • not suitable for PRN or immediate relief


75
New cards

Pregabalin

Brand: Lyrica

MOA: doesn’t bind GABA/BZD receptors → ↓ Ca influx → inhibits GABA release

Off-Label GAD

C-5

Onset: Immediate

Serious SE: suicidal thoughts

Monitor: dizziness/somnolence

76
New cards

Hydroxyzine

Brand: Vistaril

FDA approved → NO tx for underlying condition

Dose: 50-100 mg QID PRN

AE: anticholinergic, sedation

Avoid in >65 y/o (Beer’s List)